zur Übersicht: Themendossiers An­ti­bio­ti­ka­re­sis­10­zen Co­ro­na­vi­rus SARS-CoV-two Ho­möo­pa­thi­sche Arz­nei­mit­tel Lie­fe­reng­päs­se Me­di­zin­pro­duk­te Pa­ckungs­bei­la­ge Sta­tis­ti­ken Novartis fought a protracted fight with the government of India above the patenting of its drug, Gleevec, in I